The clinical role of combined circulating complement C1q and AIP for CAD with LDL-C level below 1.8mmol/L

Chenyujun Hu,Zehao Zhao,Shutong Dong,Qianyun Guo,Yujie Zhou
DOI: https://doi.org/10.1186/s12944-024-02127-8
2024-05-05
Lipids in Health and Disease
Abstract:In the past few years, circulating complement C1q involvement in atherosclerosis has garnered growing research interest in addition to the emerging recognition of the novel lipid marker named atherogenic index of plasma (AIP). Nevertheless, among patients experiencing low-density lipoprotein cholesterol (LDL-C) levels less than 1.8mmol/L, the interplay between C1q combined with the AIP for coronary artery disease (CAD) is ambiguous.
biochemistry & molecular biology,nutrition & dietetics
What problem does this paper attempt to address?